HER-2-mediated nano-delivery of molecular targeted drug potently suppresses orthotopic epithelial ovarian cancer and metastasis
- Resource Type
- Article
- Source
- In
International Journal of Pharmaceutics 25 September 2022 625 - Subject
- Language
- ISSN
- 0378-5173